What is CRM's health score?

Salesforce, Inc. (CRM) has a TradeApes health score of 72 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is CRM's estimated fair value?

Based on our 5-year discounted cash flow model, Salesforce, Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is CRM undervalued or overvalued?

Our model currently rates CRM as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for CRM... Refresh in a moment for the full analysis.

Salesforce, Inc. (CRM)

Technology Inconclusive inconclusive healthy

$185.66

Updated: 2026-06-06

TradeApes Score

Financial Strength

80 Strong

Operating Trend

71 Healthy

Relative Value

85 Strong

Capital Allocation

40 Weak

Risk

70 Healthy

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Weak liquidity — current assets below current liabilities

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.